Antares Pharma Inc (NASDAQ: ATRS) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced that it has received FDA approval. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about: The FDA approval; what we’re seeing … Read more
Antares Pharma Inc (NASDAQ: ATRS) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that the FDA has approved its new drug application, a move that will launch the company into commercial stages. Of course, the news excited investors, sending the stock on a run … Read more
Antares Pharma Inc (NASDAQ: ATRS) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into a collaboration agreement with Pfizer Inc. (NYSE: PFE) surrounding the development of a combination drug. Today, we’ll talk about: The collaboration; what we’re seeing from ATRS … Read more
Antares Pharma Inc (NASDAQ: ATRS) is headed up in the pre-market hours this morning after announcing a regulatory update surrounding XYOSTEDTM (testosterone enanthate subcutaneous injection). Of course, the update was a positive one, leading to excitement-fueled gains as the stock makes it clear into the green in the pre-market hours. Today, we’ll talk about: The … Read more
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is having an overwhelmingly strong day in the market today, and for good reason. In a press release issued early this morning, Antares Pharma, Inc. (NASDAQ: ATRS) announced that the FDA has approved a New Drug Application or NDA, that includes an AMAG Pharmaceuticals treatment. Today, we’ll talk about the approval, what … Read more
Antares Pharma Inc (NASDAQ: ATRS) is having an overwhelmingly strong day in the market today, and for good reason. The company announced that the United States Food and Drug Administration has approved a New Drug Application they submitted, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the … Read more